Esperion Therapeutics reported $23.04M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Alnylam Pharmaceuticals ALNY:US USD 98.09M 57.52M
Amarin AMRN:US USD 93.16M 23.15M
Biogen BIIB:US USD 491.5M 108.3M
Cytokinetics CYTK:US USD 25.61M 11.18M
Daiichi Sankyo 4568:JP JPY 358.38B 26.16B
Esperion Therapeutics ESPR:US USD 23.04M 4.46M
Geron GERN:US USD 10.19M 2.01M
Halozyme Therapeutics HALO:US USD 17.69M 473K
Heron Therapeutics HRTX:US USD 3.22M 3.32M
Intercept Pharmaceuticals ICPT:US USD 14.23M 7.07M
Intra Cellular Therapies ITCI:US USD 10.4M 3.82M
Minerva Neurosciences NERV:US USD 970K 437K
Moderna Inc MRNA:US USD 487M 157M
Nektar Therapeutics NKTR:US USD 12.98M 7.65M
Ptc Therapeutics PTCT:US USD 27.27M 6.41M
Puma Biotechnology PBYI:US USD 6.44M 8.49M
Sarepta Therapeutics SRPT:US USD 95.88M 22.59M
Seattle Genetics SGEN:US USD 207.85M 63.35M
Vanda Pharmaceuticals VNDA:US USD 4.98M 606K